Canada: Sample size for Cmax? [Power / Sample Size]

posted by Helmut Homepage – Vienna, Austria, 2012-12-18 19:04 (4928 d 00:00 ago) – Posting: # 9730
Views: 13,796

Dear all,

any idea how to estimate sample size for Cmax (PE within 80–125%; no 90% CI)? Nothing is mentioned in the final guidance; the draft stated in Appendix 1 (lines 752–753):

Sample size calculations, based on a standard where only the mean estimate is required to fall within the bioequivalence interval, are not possible.

Don’t agree. It’s easy enough through simulations (i.e., θ0 0.95, CVintra 40%, n 12, power 82.2%). What puzzles me is the lacking consideration of the patient’s risk. With a θ0 at the limits of the acceptance range by definition 50% of studies will pass – independent from CV and sample size.

[image]

Reminds me on this goodie. :-D No wonder that HPB didn’t introduce scaling for Cmax.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,571 registered users;
145 visitors (0 registered, 145 guests [including 14 identified bots]).
Forum time: 20:05 CEST (Europe/Vienna)

Always listen to experts.
They’ll tell you what can’t be done and why.
Then do it.    Robert A. Heinlein

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5